New glucocerebrosidase antibodies can advance research in the field of neurodegenerative disorders
Charis Ma
Krystyna Rytel
Yu Chen
Ellen Sidransky
Medical Genetics Branch,National Human Genome Research Institute,National Institutes of Health,Bethesda,MD,USA
摘要：In medical research,there are times when the introduction of a new tool can launch scientific discovery in new directions.While antibody development may be considered mundane,in the field of glucocerebrosidase(GCase)research,the dearth of validated antibodies for different applications has impeded progress in studies of disease pathogenesis and therapeutic development.The recent introduction of new,rigorously evaluated antibodies can now propel research into the link between glucocerebrosidase and Parkinson's disease(PD)as well as aspects of the pathobiology of Gaucher disease(Jong et al.,2024).
机标关键词：researchadvanceneurodfieldebrosidasglucantibodies
论文发表日期：2025-04-27
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：2( 1085-1086 )